Keryx Biopharamceuticals

Keryx Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of drugs for chronic kidney disease. Keryx Biopharmaceuticals offers Auryxia, a medication that reduces phosphate levels in the blood. It supports investigator-sponsored research conducted by independent researchers using Auryxia. It facilitates programs such as reimbursement assistance, copay support, and patient aid initiatives.Keryx Biopharmaceuticals was founded in October 1998 and is headquartered in New York.